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Abstract
Background: Despite their great impact, few genetic association studies have used hip fractures as an endpoint.
However, the association of two polymorphisms on intron 4 of estrogen receptor alpha (ESR1) with hip fractures
was recently reported in a Chinese population. The aim of this study was to investigate whether such association is
also present in Caucasians.
Methods: We analyzed those two SNPs and another neighbour SNP located on the exon 4 of ESR1 in 787 patients
with hip fractures and 953 controls from Spain.
Results: The allelic frequencies differed markedly from those reported in Asian populations. Nevertheless,
haplotypes including the rs3020314 and rs1884051 loci in intron 4 showed a significant association with hip
fractures (omnibus test p = 0.006 in the whole group and 0.00005 in women). In the sex-stratified analysis, the
association was significant in females, but not in males. In women, the CA haplotype appeared to have a
protective influence, being present in 6.5% of the controls, but only in 3% of patients with fractures (odds ratio
0.39; 95% confidence interval 0.26-0.59; estimated population preventive fraction 3.5%). The inclusion of the
rs1801132 SNP of exon 4 further increased the statistical significance of the association (odds ratio 0.17; 95% CI
0.08-0.37; p = 0.00001). Each SNP appeared to contribute independently to the association. No genotype-related
differences in gene expression were found in 42 femoral bone samples.
Conclusions: This study confirms the association of some polymorphisms in the region of exon 4/intron 4 of ESR1
and hip fractures in women. However, there are marked differences in allele frequencies between Asian and
Caucasian populations.
Background
Osteoporosis has a strong genetic component, and twin
and family studies have shown that the variation of ske-
letal traits such as bone mineral density and bone size
depends on heritable factors to a large extent [1,2].
Thus, for the past 15 years many studies have been per-
formed in order to identify the genes responsible for
such hereditary influence. Sex steroids play a critical
role in bone homeostasis [3]. Hence, not surprisingly,
estrogen-related genes, including enzymes involved in
estrogen synthesis [4,5] and the estrogen receptor alpha
gene (ESR1) have been widely studied. ESR1 is located
on chromosome 6q25 and comprises 8 exons [6]. After
the seminal work by Kobayashi et al [7], many investiga-
tors explored the association between ESR1 polymorph-
isms and bone phenotypes. In the majority of studies,
some closely linked polymorphisms situated in intron 1,
frequently characterized by using the restriction
enzymes PvuII and XbaI, were analyzed. The results
have been controversial, with some, but not all studies
showing an association of those polymorphisms with
BMD or fractures [8-12]. Nevertheless, a large meta-
analyses and a multicenter study showed evidence for
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tebral fractures [10,11]. Recent genome-wide association
(GWA) studies also showed a very significant associa-
tion between certain ESR1 polymorphisms and BMD
[13,14].
Low BMD is associated with an increased risk of frac-
tures, but BMD by itself has limited ability to predict
the overall fracture risk [15-17]. Therefore, from a clini-
cal point of view, osteoporotic fractures, and particularly
hip fractures, are a more relevant outcome than BMD.
However, few genetic studies have been designed with
hip fractures as an endpoint, in part due to the difficul-
ties inherent to studies including elderly individuals. On
the other hand, it has been suggested that the relative
importance of genetic factors may decrease with advan-
cing age [18,19]. However, a recently published study
found a strong association of some frequent polymorph-
isms in the intron 4 of ESR1 and hip fractures in Asian
population, whereas no association was found with the
most widely studied polymorphisms situated in proximal
regions of the gene (such as the “PvuII” locus in intron
1) [20]. The aim of this study was to replicate those
results in a Caucasian population and explore the poten-
tial functional consequences by determining gene
expression in the bone tissue.
Methods
Study subjects
This was a case-control study which included 1740
individuals over 50 years of age. Patients admitted to
hospital with a hip fracture were included (n = 787,
258 men and 529 women). Those with fractures due to
high-impact trauma (such as traffic accidents and falls
from a height), diseases causing secondary osteoporosis
(cancer, rheumatoid arthritis, malabsorption, severe
systemic diseases, etc) or taking drugs known to have
a deleterious effect on bone metabolism (corticoster-
oids, anticonvulsants) were excluded. Control subjects
(n = 953, 159 men and 794 women) over 50 years of
age were recruited by voice and written announce-
ments from various sources to prevent a preferential
selection bias (hospital workers, civic associations, reli-
gious groups and geriatric residences). They were
selected among individuals without known osteoporo-
tic fractures and not receiving anti-osteoporotic ther-
apy or hormone replacement therapy, either at the
time of study or in the past. All subjects were inter-
viewed by one of the investigators in order to check
the absence of exclusion criteria (as in hip fracture
patients). Subjects with non-Spanish ancestry were
excluded. The study protocol was approved by the
Institutional Committee of Ethics in Clinical Research,
and informed consent was obtained from study sub-
jects or their representatives.
Genotyping
DNA was isolated from the peripheral blood or from
buccal swabs with a commercial kit (Qiagen, Hilden,
Germany), following the manufacturer’s instructions.
We studied two SNPs situated in intron 4 of the ESR1
gene, which had been previously associated with hip
fractures in the Chinese population (rs3020314 and
rs1884051)[20]. We also studied the neighbor rs1801132
polymorphism, located on exon 4, which was associated
with vertebral fractures in white women from the USA
[21]. They were typed using Taqman assays (Applied
Biosystems; Foster City, CA). Random samples were
used as replicate controls to check the consistency of
results. The genotyping rate was >98.5% for all three
SNPs.
Gene expression
ESR1 expression was determined by reverse transcrip-
tion (RT)-real time quantitative PCR. Bone samples
were obtained from the femoral neck during hip repla-
cement procedures for hip fractures in 42 patients. The
periosteum and the cortical bone were removed. Small
trabecular fragments were extensively washed with PBS,
s n a p - f r o z e ni nl i q u i dn i t r o g e na n ds t o r e da t- 7 0 ° C .
Unthawed fragments were mashed and pulverized with
a tissue homogenizer into Trizol (Invitrogen) to extract
RNA. Then RNA was reverse-transcribed with the
Superscript III kit (Invitrogen), using random hexamers
as primers. In negative control reactions reverse tran-
scriptase was omitted. After RT, gene expression level
was determined by real-time PCR in an ABI7300 appa-
ratus (Applied Biosystems). The reactions were per-
formed in triplicate in 96-well plates containing aliquots
of the cDNA obtained by reverse transcription, 5 μlo f
universal PCR master mix, and specific primers and
probe complementary to exons 3-4 of ESR1 (Taqman
Gene Expression Assays, ref. Hs00174860_m1, Applied
Biosystems). The cycle threshold (Ct) was determined.
This represents the cycle at which a significant increase
in fluorescence is first detected and is inversely related
to the amount of target cDNA in the starting material.
The results were normalized to TBP (TATA box bind-
ing protein) expression analyzed in the same reaction
plate, and estimated as 2
Δ,w h e r eΔ is the difference of
the TBP Ct minus the ESR1 Ct. We confirmed the pre-
sence of abundant transcripts of factors typical for cells
of the osteoblastic lineage, such as alkaline phosphatase,
osteocalcin and sclerostin in those fragments (not
shown).
Statistical analyses
The Hardy-Weinberg equilibrium, the linkage disequili-
brium parameters (D’ and r
2) and the haplotypic blocks
were estimated with Haploview software [22]. The
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with the Cochrane-Armitage trend test and the c
2 test
for dominant and recessive models implemented in
Plink software [23]. The association between haplotypes
and fractures was tested by an omnibus c
2 test, followed
by testing the association of individual haplotypes, in
case of a significant global test. The association was also
tested after adjusting for age as a covariate by means of
a likelihood ratio c
2 test. Conditional haplotype analyses
were used to explore the independent effect of each
SNP within the haplotypic context. All these analyses
were done with Plink. Permutation corrections of p-
values were computed with Haploview. The non-para-
metric Kruskal-wallis test, implemented in SPSS soft-
ware (SPSS Inc, Chicago, IL, USA) was used to analyze
the differences in gene expression between subjects with
different genotypes. Power calculations were done with
Quanto software http://hydra.usc.edu/gxe. We estimated
the study had an a priori power over 85% to find a risk
ratio difference of 30% associated with polymorphisms
with a minor allele frequency over 20%, under an addi-
tive genetic model.
Results
The mean age of patients was 83 ± 8 yr; age of controls
was 74 ± 9 yr. Patients with fractures had more frequent
comorbid diseases (table 1). The allelic frequencies are
shown in table 2. They were similar to those reported in
the Caucasian Hapmap database, but rather different
from the frequencies in Asian populations. There was
no evidence for departure from the Hardy-Weinberg
equilibrium. The three SNPs studied were in linkage dis-
equilibrium, with D’ values between 0.79 and 0.94, and
r
2 values between 0.44 and 0.76 (figure 1). Loci
rs3020314 and rs1884051 were considered as a haploty-
pic block according to the 4-gamet rule.
In the whole group there was a non-statistically signifi-
cant trend for association between hip fractures and the
rs1801132 (p = 0.09 and 0.05 for the codominant and
recessive models) and rs3020314 (p = 0.09 and 0.06 for
the codominant and recessive models) polymorphisms.
In women, the three polymorphisms showed a marginally
significant association with fractures in the unadjusted
analysis (rs1801132, p = 0.03; rs3020314, p = 0.04;
rs1884051, p = 0.03), but it was no longer significant (p >
0.2) after including age as a covariate. The results were
not statistically significant in the male group.
However, the haplotypic analysis revealed a strong
association between gene variations and fracture risk, in
the whole group and in the female group (figure 1).
Haplotypes including rs3020314 and rs1884051 loci
showed a significant association (omnibus test p = 0.006
in the whole group and 0.00005 in women). The inclu-
sion of the rs1801132 locus further increased the statis-
tical significance of the association (figure 1). The
results remained significant after taking into considera-
tion the error inflation by permutation analyses. Permu-
tation p-values were 0.008 and 0.0002, for the 2-SNP
(rs3020314- rs1884051) and the 3-SNP analyses, respec-
tively. In the conditional analysis, all three SNPs
appeared to contribute significantly to the association of
the haplotypes with fractures (all p-values < 0.007). The
association of individual haplotypes with fractures is
shown in table 3. It was driven by the CA haplotype, as
when this haplotype was controlled for the remaining
haplotype set was no longer associated with fractures in
the omnibus test. The CA haplotype appeared to have a
protective role, with a frequency of 6.5% in the control
group and 3% in the fracture group. Similarly, the fre-
quency of the 3-SNP GCA haplotype was 3.2% in the
control group and 0.7% in the fracture group.
Since the average age was somewhat higher in the
fracture group than in the control group, we repeated
the haplotypic analyses including age as a covariate. The
association between estrogen receptor haplotypes and
fractures remained statistically significant after control-
ling for age (p = 0.03 and p = 0.02 for the 2-SNP and
the 3-SNP haplotype omnibus tests, respectively). We
also performed an association analysis including only
individuals of 70-85 years of age in order to get age-
matched patient and control groups. This subgroup
included 520 fractured patients (age 79 ± 4) and 376
controls of similar age (age 78 ± 5). As in the previous
analysis, there was a significant association between the
2-SNP and 3-SNP haplotypes and fractures in men and
women combined and in the female group. The 3-SNP
omnibus test showed p-values of 0.02 and 0.001, for the
Table 1 Clinical characteristics of patients and controls.
Women Men
Controls Patients Controls Patients
Age 73 (9) 83 (8) 74 (10) 81 (8)
Weight
1, kg 66 (10) 65 (12) 78 (12) 72 (8)
Height
1, cm 154 (6) 156 (6) 166 (6) 164 (7)
Body mass index
1, kg/m
2 27.9 (4.2) 26.6 (4.9) 28.3 (3,6) 26.8 (5.0)
Calcium intake
2, mg 660 (364) 631 (355) 605 (363) 579 (333)
Alcohol
3, % 4 1 40 19
Current smokers, % 1 2 9 15
Prior stroke or TIA, % 3 9 8 19
Coronary heart disease, % 3 7 13 14
Congestive heart failure,
%
5939
Diabetes mellitus, % 13 22 15 25
Dementia, % 4 36 4 35
Numbers represent means (and SD) or percentages.
1Weight, height and body mass index data were available only in 41 patients
with fractures
2Calcium intake from dairy products, mg/day
3Alcohol intake higher than 10 g/day
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values for the most significant haplotype (GCA) were
0.001 and 0.0001, respectively. In men, the omnibus test
p-value was 0.17. A Bayesian analysis did not reveal any
suggestion of a plausible association between haplotypes
and fractures in the male group (not shown). Despite
their similar age, patients of 70-85 years of age had a
higher frequency of comorbid diseases than the control
group, particularly stroke, diabetes mellitus and demen-
tia. Nevertheless, when women with those frequent dis-
eases were excluded, the estrogen receptor haplotypes
remained significantly associated with a reduced risk of
fractures (CA haplotype OR 0.41, p = 0.011; GCA hap-
lotype OR 0.19, p = 0.027).
Gene expression was studied in 42 bone samples. We
found no significant differences in the abundance of estro-
gen receptor transcripts across different genotypes. The
results for the rs1884051 genotypes are shown in figure 2.
Similar results were found when gene expression was ana-
lyzed in relation to rs3020314 and rs1884051SNP alleles
(not shown). The sample size did not allow to analyze the
relationship between haplotypes and gene expression.
Table 2 Allelic frequencies in the present study and other Caucasian and Asian populations
Present study Hapmap-CEU Wang’s study[20] Hapmap-HCB
rs1801132 C 0.82 0.82 0.52 0.49
G 0.19 0.18 0.48 0.51
rs3020314 C 0.27 0.29 0.82 0.81
T 0.73 0.71 0.18 0.19
rs1884051 A 0.76 0.70 0.48 0.51
G 0.24 0.30 0.52 0.46
CEU: Utah residents with Northern and Western European ancestry; HCB: Han Chinese in Beijing. The differences between the present study and Wang’s study
were statistically significant for the three loci analyzed (p < 0.0001).
Figure 1 ESR1 haplotypes and hip fractures. Diagram showing the association of 2-SNP (rs3020314 and rs1884051) and 3-SNP (rs1801132,
rs3020314 and rs1884051) haplotypes with hip fractures in the whole group of men and women combined and in the female group. The
numbers represent the p-values of the omnibus c
2 test including all haplotypes and the result for the individual haplotype showing the most
significant association. The upper part of the figure shows the between-locus linkage disequilibrium (D’).
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Wang et al recently performed an ESR1 gene-wide associa-
tion study in a moderate-size group of Chinese men and
women, including 350 patients with hip fractures and 350
controls [20]. They found that a common haplotype in
intron 4, present in 57% of control subjects, was associated
with a decreased risk of hip fractures, with and odds ratio
of 0.68 (confidence interval 0.55-0.84). Hip fractures are
among the most devastating osteoporotic fractures. There-
fore, the findings in Wang’s report were of great scientific
(and possibly practical) interest.
Our study, aimed to replicate those findings in Cauca-
sians, confirmed a strong association of the haplotypes
of the intron 4 of ESR1 with hip fractures, particularly
in women. However, the allelic frequencies of the SNPs
involved, and consequently the haplotype frequencies,
were rather different from those found in Chinese. Alle-
lic frequencies were less balanced in our population,
and the frequency of the haplotypes influencing fracture
risk was much lower (6.5%, versus 57% in the Chinese).
Therefore, their impact at the population level must also
be lower in Caucasians than in the Asians. Although we
Table 3 Association of ESR1 haplotypes with hip fractures in women.
Frequency in cases (%) Frequency in controls (%) OR (95% CI) p-value
2-SNP
CG 23.6 20.1 1 -
TG 0.8 1.2 0.54 (0.26-1.16) 0.22
CA 3.0 6.5 0.39 (0.26-0.59) 1.8 × 10
-5
TA 72.6 72.2 0.85 (0.70-1.0) 0.77
3-SNP
GCG 14.7 13.5 1 -
CCG 8.9 6.8 1.18 (0.83-1.69) 0.05
CTG 0.8 1.2 0.58 (0.27-1.25) 0.22
GCA 0.6 3.2 0.17 (0.08-0.37) 8.6 × 10
-7
CCA 2.4 3.3 0.67 (0.4-1.13) 0.13
GTA 1.4 1.9 0.65 (0.32-1.31) 0.26
CTA 71.2 70.1 0.92 (0.73-1.17) 0.52
2-SNP haplotypes include rs3020314 and rs1884051
3-SNP haplotypes include rs1801132, rs3020314 and rs1884051
Figure 2 ESR1 alleles and expression. Abundance of estrogen receptor gene transcripts in bone samples from patients with hip fractures
according to the rs1884051 genotypes (n = 26, 14 and 2). The results are expressed as arbitrary units, normalized by the housekeeping gene TBP.
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study like this, assuming a lifetime frequency of hip frac-
tures about 15%, it could be estimated that the popula-
tion preventive fraction due to the estrogen receptor
haplotype would be about 3.5%. The differences in the
allelic frequency distributions are not unique to our stu-
dies. According to Hapmap data, they reflect the differ-
ences between the general Caucasian and Asian
populations. We also genotyped a nearby SNP located
on exon 4, about 5 kb upstream from those reported by
Wang, which has been associated with vertebral frac-
tures in a candidate gene study of white American
women from the SOF cohort. The inclusion of this SNP
in the haplotypic analysis resulted in a stronger associa-
tion signal.
The incidence of hip fractures increases exponentially
with age. Given the difficulty to recruit suitable very old
controls, our control and fracture groups were not well
age-matched. On the other hand, the frequency of
comorbid disorders was higher in the fracture group,
independently of age. These represent potential limita-
tions of the study. In general, the younger age of the
controls would be expected to bias our study towards
the null result (as some of the control individuals may
suffer a fracture in later years). However, other type of
bias could theoretically exist if, for instance, the
polymorphisms were associated with life expectancy.
Therefore, after the crude analysis we performed both
an age-adjusted analysis and an analysis of the associa-
tion including only patients and controls of similar
“middle” age. Both analyses confirmed the association
between ESR1 haplotypes and hip fractures. Bone
mineral density is a well-known risk factor for fractures,
but other factors, including body weight, are also impor-
tant. We could not establish to what extent the ESR1
haplotypes association with fractures was dependent on
those factors because we have BMD and anthropometric
data in only a minority of patients with fractures. As in
other studies [24], we found a higher frequency of
comorbid diseases in the fracture group than in the con-
trol group, particularly cerebrovascular diseases, demen-
tia and diabetes mellitus. However, the association of
ESR1 haplotypes with fractures appeared to be indepen-
dent of those comorbidities.
The mechanisms explaining this association are
unclear. The conditional analyses suggested that each of
the three SNPs had an independent significant contribu-
tion to the association. Therefore, our study does not
allow to identify a causal SNP. Since rs11801132 is a
synonymous polymorphism and the two other poly-
morphisms are located in an intronic region, changes in
the aminoacid sequence do not explain the association
with hip fractures. Allele-related differences in gene
expression are a more likely explanation. However, we
have not been able to show genotype-related differences
in estrogen receptor transcripts in bone tissue. Never-
theless, given the number of bone samples, the study
did not have enough power to analyze possible differ-
ences in gene expression at the haplotypic level. In the
Chinese population, Wang found that the CC haplotype
(rs3020314-rs1884051) was associated with a decreased
fracture risk (OR 0.68; 95% confidence interval 0.55-
0.84). They designed the rs1884051 polymorphism
according to the alleles in the reverse DNA strand.
Therefore, that haplotype corresponds to the CG haplo-
type in our study. Interestingly, we did not observe an
effect of such haplotype on fracture risk, but we did find
a protective effect of the CA haplotype (odds ratio 0.49;
95% confidence interval 0.26-0.59). Taking together the
different haplotypes involved, the differences in allelic
and haplotype frequencies in the Chinese and Caucasian
populations and the lack of differences in gene expres-
sion at the allele level suggest that the association with
fracture risk is not directly due to the SNPs included in
these studies, but to other polymorphisms in linkage
disequilibrium.
Conclusions
In conclusion, we have confirmed a significant associa-
tion of genetic variants in the region of exon 4-intron 4
of the ESR1 and hip fractures in the Caucasian women.
This and previous results in Asian population suggest
that, regarding hip fractures, the variation along this
region may be more important than the most widely
studied proximal region of the gene. Given the devastat-
ing consequences of these fractures, further studies are
warranted to identify the causal polymorphisms and to
elucidate the molecular mechanisms responsible for
such association. On the other hand, it may be interest-
ing to explore if the differences in the allelic frequency
distributions between Asian and Caucasian populations
are related to the worldwide regional differences in the
incidence of hip fractures.
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